2009
Prevention of Lesion Recurrence in Endovascular Devices
Rochier A, Sumpio B. Prevention of Lesion Recurrence in Endovascular Devices. 2009, 431-447. DOI: 10.1007/978-1-4419-1387-6_30.Peer-Reviewed Original ResearchIliac arteryAutogenous bypass graftsMulticenter trialBypass graftLesion recurrenceEndovascular methodsStent placementFemoral arteryAtherosclerotic obstructionDrug AdministrationUS FoodAdequate conduitArteryEndovascular devicesInvasive surgeryStentsHuman arteriesFavorable resultsOptimal techniqueSuitable riskAngioplastyIliacPatientsSurgeryRecurrence
2005
Cilostazol Inhibits Leukocyte Integrin Mac-1, Leading to a Potential Reduction in Restenosis After Coronary Stent Implantation
Sumpio BE, Aruny J. Cilostazol Inhibits Leukocyte Integrin Mac-1, Leading to a Potential Reduction in Restenosis After Coronary Stent Implantation. Perspectives In Vascular Surgery And Endovascular Therapy 2005, 17: 265-267. PMID: 16273169, DOI: 10.1177/153100350501700317.Peer-Reviewed Original ResearchCoronary stent implantationCoronary stentingStent implantationRate of restenosisLeukocyte integrin Mac-1Mechanism of restenosisP-selection expressionIntegrin Mac-1Cilostazol groupConsecutive patientsStent placementPhosphodiesterase IIIRestenosisMac-1Granule releasePatientsCilostazolStentingP-selectionLower ratesUpregulationPlateletsImplantationInhibitsTiclopidine